Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795780 · ClinicalTrials.gov registry record · Phase 2
Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
A Phase 2 study, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 79
- Enrollment target
NCT02795780 is a Phase 2 study that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 79 participants.
The verdict
NCT02795780, a Phase 2 study, has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 79 participants
- Enrollment target
Study Summary
This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.
Interventions
- DRUG Flortaucipir F18
- PROCEDURE PET Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-08-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02795780
The ClinicalTrials.gov registry entry for NCT02795780 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Flortaucipir F18 is the first listed.
NCT02795780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02795780 about?
NCT02795780 is a clinical study titled "Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05". This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.
What is the current status of trial NCT02795780?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 2016-08. Estimated completion is 2017-08-28.
What interventions are being tested in trial NCT02795780?
The interventions under investigation include: Flortaucipir F18 (DRUG), PET Scan (PROCEDURE).
Who is sponsoring clinical trial NCT02795780?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.